Amendola, a nationally recognized, award-winning healthcare technology and life sciences public relations and marketing firm, announced that it has been selected by Red Rover Health, which enables healthcare providers to integrate
third-party solutions
into their electronic health record (EHR) systems, to execute a national public relations program.
Red Rover Health is collaborating with Amendola to generate awareness about its healthcare integration platform that allows “best of breed” healthcare software solutions to securely integrate with EHR systems. As a result of the platform’s availability, healthcare organizations now have access to world-class solutions to make the most of their existing EHR investments.
Amendola is crafting a comprehensive
PR
plan to showcase Red Rover Health’s industry-leading technology and services, accomplishments, customer wins, and industry partnerships.
“
Red Rover
serves as a central platform for healthcare innovation,” said
John Orosco
, CEO, Red Rover Health. “Our partnership with Amendola will highlight how engaging with an integration partner to handle interoperability needs is a practical approach for healthcare organizations looking to enhance data exchange between different systems.”
Jodi Amendola
, president of Amendola, said: “EHR systems are frequently designed as one-size-fits all solutions with limited customization options that do not align with providers’ real-world workflows. This disconnect can create frustration, inefficiency, and unnecessary costs for providers. Our strategic PR and content program with
Red Rover
is educating the market on how health systems can improve interoperability, streamline workflows, and enhance data exchange with the right EHR integration partner.”
Recently,
Red Rover
earned SOC 2 Type 2 certification after a rigorous audit process confirmed that its platform’s information security practices, policies, procedures, and operations meet the SOC 2 standards for security, availability and confidentiality set by the American Institute of CPAs.